![]() |
Volumn 7, Issue 5, 2005, Pages 191-192
|
Clinical and laboratory characteristics of drug-induced vasculitic syndromes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
CARBIMAZOLE;
CARDIOLIPIN ANTIBODY;
HISTONE ANTIBODY;
IMMUNOGLOBULIN M;
IMMUNOSUPPRESSIVE AGENT;
MYELOBLASTIN;
MYELOPEROXIDASE;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
PROPYLTHIOURACIL;
THIAMAZOLE;
ARTHRALGIA;
ARTICLE;
CHURG STRAUSS SYNDROME;
CLINICAL FEATURE;
DIFFERENTIAL DIAGNOSIS;
DRUG INDUCED DISEASE;
DRUG WITHDRAWAL;
GENETIC PREDISPOSITION;
GRAVES DISEASE;
HUMAN;
IDIOPATHIC DISEASE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FAILURE;
LABORATORY TEST;
LUNG HEMORRHAGE;
LUPUS ERYTHEMATOSUS;
MICROSCOPIC POLYANGIITIS;
RENOVASCULAR DISEASE;
SKIN MANIFESTATION;
VASCULITIS;
WEGENER GRANULOMATOSIS;
ANTIBODIES, ANTICARDIOLIPIN;
ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC;
ANTITHYROID AGENTS;
AUTOANTIBODIES;
AUTOIMMUNE DISEASES;
CHURG-STRAUSS SYNDROME;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
IMMUNOGLOBULIN M;
KIDNEY;
KIDNEY FAILURE, ACUTE;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
METHIMAZOLE;
PROPYLTHIOURACIL;
SKIN;
THROMBOPHILIA;
VASCULITIS, HYPERSENSITIVITY;
WEGENER GRANULOMATOSIS;
|
EID: 25144513504
PISSN: 14786354
EISSN: None
Source Type: Journal
DOI: 10.1186/ar1805 Document Type: Article |
Times cited : (39)
|
References (7)
|